On Demand
Therapeutic Update 2026
15 Hour Bundle
About This Course
This course provides 15 contact hours of pharmacy CE and (1.5 CEU) of live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/CME credit.
Recorded in Key West on April of 2026
Price $250 for 15 Hours
Learning Objectives
-
1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms, MedWatch alerts and CDC immunization schedules.
2. Discuss thenew drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
3. Describe their adverse effects and drug interaction that may affect patient compliance.
4. Compare efficacy, dosage and cost to existing agents.
5. Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients.
6. Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.
-
1. Discuss the new drugs with respect to their pharmacology, pharmacokinetics, approved and unapproved indications.
2. Describe their adverse effects and drug interaction that may affect patient compliance.
3. Compare efficacy, dosage and cost to existing agents.
4. Discuss the patient oriented outcomes or evidence that may or may not exist for each of the new medications and when they may or may not be appropriate to recommend for selected patients.
5. Compare pharmacotherapy outcomes vs cost/benefit between newly approved agents and existing or lower cost agents.
-
1. Discuss why individuals with profound autism have reduced access to inpatient psychiatric hospitalization.
2. Define polypharmacy.
3. Identify three reasons for polypharmacy in people with profound autism.
4. Apply deprescribing strategies to a clinical case example.
5. Define diagnostic overshadowing and evaluate factors that may contribute to it using a clinical case example.
6. Identify three common psychotropic side effects and assess how they contribute to aggression and self-injurious behaviors in people with intellectual disabilities.
7. Distinguish between affective and mood lability and describe how those differences influence treatment planning.
8. Describe the diagnostic and treatment differences of catatonia in people with and without an intellectual disability.
9. Formulate a treatment plan for an individual with profound autism and excited catatonia
Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP
Professor Emeritus of Family Medicine, Department of Family Medicine, Medical University of South Carolina, Professor Emeritus of Clinical Pharmacy & Outcome Sciences, South Carolina College of Pharmacy, MUSC Campus, Charleston, SC.
More …
Dr. Michael Cummings MD
Vice Chair and Assistant Professor, Department of Psychiatry, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, The State University ofNew York. Buffalo, NY
Accreditation Information
PHARMACISTS: University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for all pharmacists.
University Learning Systems is approved by CE Broker, Tracking #50-11357 and reports to the Florida Board of Pharmacy.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS: Canadian Council on Continuing Education in Pharmacy (CCCEP) accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE). This credit is applicable to health professionals who may require pharmacology credit.
NURSE PRACTITIONERS American Nurses Credentialing Center (ANCC) and National Certification Corporation (NCC) accept ACPE and AAFP credit. University Learning Systems courses fulfill the pharmacology requirements for ANCC Category 1 Continuing Education Hours for certification renewal.
American Association of Nurse Practitioners (AANP) accepts AAFP/ AMA PRA Category 1™.
NURSESUniversity Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357: Approved these Boards of Nursing: Arkansas, Florida, District of Columbia, Georgia, Kentucky, New Mexico, North Dakota, South Carolina, West VirginiaThe same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.
PHYSICIANS/ PHYSICIAN ASSISTANTS: The AAFP has reviewed Therapeutic Update 2026 and deemed it acceptable for up to 15.00 Live AAFP Prescribed credit(s). Term of Approval is from 04/28/2026 to 12/31/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1. CME programs approved by the AAFP are eligible for Category 2 credit (or Category 1-A under special circumstances) through the American Osteopathic Association (AOA). American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP. Physician assistants may report the number of hours stated above of Category I credit for completing this program. University Learning Systems is approved by CE Broker, Tracking #50-11357 and reports to the Florida Board of Medicine.
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.
OTHER HEALTH PROFESSIONALS: Contact your respective board regarding approval
See ULS Accredation Statements for more details.